Rejuve Biotech Inc. — Form C/A (Regulation Crowdfunding)
Rejuve Biotech Inc. of Orange, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2024-02-27. Target raise $10K, up to $5.0M. Offered through NetCapital Funding Portal Inc..
Offering
- Filed: 2024-02-27
- Form: C/A
- Accession: 0001669191-24-000204
- Target amount: $10K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 1,201
- Price: $8.3300
- Deadline: 2024-04-26
- Funding portal / intermediary: NetCapital Funding Portal Inc.
- Intermediary file number: 007-00035
- Intermediary CRD: 283596
Issuer
- CIK: 0001994911
- Website: https://www.rejuve.bio/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2022-12-01
- Address: 982A N. Batavia Street, Orange, CA, 92867
- Employees: 0
People (6)
| Name | Role | Location |
|---|
| Kennedy Schaal | Board Member | ORANGE, CA |
| Kennedy Schaal | CEO | ORANGE, CA |
| Kennedy Schaal | Principal Accounting Officer | ORANGE, CA |
| Kennedy Schaal | Principal Executive Officer | ORANGE, CA |
| Kennedy Schaal | Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, Board Member | ORANGE, CA |
| Kennedy Schaal | Principal Financial Officer | ORANGE, CA |
Reg CF filing history (9)
More